Niagen Bioscience (NAGE) Payables: 2011-2025
Historic Payables for Niagen Bioscience (NAGE) over the last 12 years, with Sep 2025 value amounting to $12.7 million.
- Niagen Bioscience's Payables rose 84.59% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.6 million, marking a year-over-year increase of 37.54%. This contributed to the annual value of $8.5 million for FY2024, which is 16.67% down from last year.
- Latest data reveals that Niagen Bioscience reported Payables of $12.7 million as of Q3 2025, which was down 6.86% from $13.7 million recorded in Q2 2025.
- Over the past 5 years, Niagen Bioscience's Payables peaked at $13.7 million during Q2 2025, and registered a low of $6.9 million during Q3 2024.
- Its 3-year average for Payables is $9.7 million, with a median of $9.2 million in 2023.
- In the last 5 years, Niagen Bioscience's Payables fell by 24.95% in 2024 and then soared by 84.59% in 2025.
- Quarterly analysis of 5 years shows Niagen Bioscience's Payables stood at $10.4 million in 2021, then dropped by 7.14% to $9.7 million in 2022, then increased by 5.71% to $10.2 million in 2023, then decreased by 16.67% to $8.5 million in 2024, then surged by 84.59% to $12.7 million in 2025.
- Its Payables stands at $12.7 million for Q3 2025, versus $13.7 million for Q2 2025 and $10.6 million for Q1 2025.